Boundless Bio Stock Quote BOLD - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.52

Bid

3.38

Ask

3.50

Volume

29,608

3.32 Day's Range 3.56

2.85 52 Week Range 59.97

Market Cap

78.336M

Previous Close

3.45

Open

3.48

Last Trade

3.3801

Last Trade Time

Financial Volume

$ 100,660

VWAP

3.3997

Average Volume (3m)

68,800

Shares Outstanding

22,254,537

Dividend Yield

PE Ratio

-1.59

Earnings Per Share (EPS)

-2.22

Revenue

Net Profit

-49.43M

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical t... Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.boundlessbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Boundless Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BOLD. The last closing price for Boundless Bio was $3.45. Over the last year, Boundless Bio shares have traded in a share price range of $ 2.85 to $ 59.97.

Boundless Bio currently has 22,254,537 shares outstanding. The market capitalization of Boundless Bio is $76.78 million. Boundless Bio has a price to earnings ratio (PE ratio) of -1.59.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-0.564971751412	3.54	4.72	3.12	105025	4.05669693	CS
4	-0.12	-3.2967032967	3.64	4.72	3.04	60280	3.71940376	CS
12	-0.72	-16.9811320755	4.24	4.72	2.85	68800	3.63446941	CS
26	-56.45	-94.1303985326	59.97	59.97	2.85	115326	8.04001655	CS
52	-56.45	-94.1303985326	59.97	59.97	2.85	58121	8.04001655	CS
156	-56.45	-94.1303985326	59.97	59.97	2.85	19425	8.04001655	CS
260	-26.23	-88.1680672269	29.75	60	2.85	96742	46.59193177	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.05 (110.00%)	257.77M
TBIOTelesis Bio Inc	$ 3.98 (71.55%)	25.89M
ATGLAlpha Technology Group Limited	$ 3.68 (71.16%)	14.33M
KTTAPasithea Therapeutics Corporation	$ 5.73 (49.02%)	57.24M
CNEYCN Energy Group Inc	$ 0.5799 (39.73%)	105.6M
XPONExpion360 Inc	$ 0.0631 (-24.88%)	52.58M
SMCXDefiance Daily Target 2X Long SMCI ETF	$ 7.2601 (-24.69%)	4.84M
PGYPagaya Technologies Ltd	$ 9.645 (-22.53%)	14.01M
DBGIDigital Brands Group Inc	$ 0.310301 (-22.42%)	822.02k
MDXHMDxHealth SA	$ 1.99 (-21.65%)	1.61M
NVDANVIDIA Corporation	$ 124.04 (0.43%)	302.67M
DUOFangDD Network Group Ltd	$ 1.05 (110.00%)	257.78M
SQQQProShares UltraPro Short QQQ	$ 7.32 (-2.01%)	160.61M
HOLOMicroCloud Hologram Inc	$ 0.2866 (18.92%)	111.05M
MUMicron Technology Inc	$ 109.88 (14.73%)	107.97M